Bernstein analyst Lee Hambright raised the firm’s price target on Tandem Diabetes (TNDM) to $44 from $42 and keeps an Outperform rating on the ...
The National Diabetes Prevention Program was cost-saving and potentially cost-effective over 2 years among patients with prediabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback